Rotavirus vaccine "well worth the cost"
A real NICE controversy over QALY in the UK
UK NICE has recommended the use of natalizumab [Tysabri; Biogen, Elan] in patients with highly active, relapsing-remitting multiple sclerosis (MS).
UK NICE releases guidance on paediatric UTIs
HPV vaccination programmes require careful consideration
US asthma management guidelines updated
NICE OKs arthritis therapies, not pemetrexed for NSCLC
Unlicensed and off-label use of medicines in neonates remains high despite efforts in the US and Europe to support paediatric drug research,
Cost-effective cervical cancer prevention possible in Brazil
Atorvastatin cost saving for preventing cardiovascular events
Hospitalised patients with HIV infections are increasing in age and have a higher number of diagnoses,
Costs for third-line gefitinib for NSCLC are acceptable
A simple education programme appears to effectively reduce sevoflurane use at a children's hospital in Australia,
School 'flu' vaccination campaigns require considerable resources
Higher cost, greater satisfaction with parecoxib for postop pain
Time to terminate tuberculosis testing in toddlers?
Stem cell transplants favourable for acute leukaemia
Amorolfine + terbinafine worth it for onychomycosis
Combinations of anti-inflammatory agents are used by more than half of patients with acute gout in US hospitals,
On-demand relaparotomy for severe peritonitis saves ...
From 1999 to 2004, the use of thrombolysis in the treatment of acute ischaemic stroke in the US was uncommon,
The use of complementary and alternative medicines (CAM) is high among children, and disclosure rates to physicians are low,
In-home palliative care intervention improves life at less cost
Bullying bumps up medicine use among school kids
Ciclesonide comparable to budesonide for asthma in kids
A combination of tamoxifen, temozolomide and thalidomide effectively improves QOL among patients with malignant astrocytomas,
PDE-5 inhibitors don't improve psychological aspects of ED
Mannitol [Bronchitol]* may improve mucus clearance and QOL among patients with bronchiectasis,
UK optometrists will gain independent prescribing powers,
The UK MHRA has announced that products containing pseudoephedrine or ephedrine will retain OTC status,
The World Health Organization has updated its official guidance on the clinical management of avian influenza A (H5N1) virus infection.